All the buzz over combining experimental immune-boosting drugs with checkpoint inhibitors could fizzle into disappointment. In other public health news: eye treatments, aging athletes, the E. coli outbreak, hearing aids, and Ebola.
from Kaiser Health News https://ift.tt/2IQaMHF
May 17, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Doctors Who Treat Gunshot Victims Tell NRA Why Gun Safety Is Their ‘Highway’After the NRA said "anti-gun'' physicians should stay in their own lane, a growing number of doctors have mounted a social media campaign with the hashtag "ThisIsOurLane" and gained support from the U.S. Surgeon General Jerom… Read More
State Highlights: Flames From California Wildfire Are Banked, But Not The Trauma For Survivors; ‘Supported Housing’ Deaths In New York Questioned By JudgeMedia outlets report on news from California, New York, Michigan, New Hampshire, Massachusetts, Maryland, Kansas, Georgia, Wisconsin, Florida and Minnesota. from Kaiser Health News https://ift.tt/2QOHuNK … Read More
Aging Roundup: Emergency Care; Elder Abuse; Alzheimer’s; And Holiday CheerMedia outlets take a look at various issues surrounding aging, including what to look for when trying to spot elder abuse; how difficult the emergency room can be for seniors; how to keep the aging body and brain healthy; and… Read More
Weeklong Strike Set To Start For 4,000 Kaiser Mental Health Professionals In California“This strike is a clear message to Kaiser that its mental health clinicians won’t stand by silently while their patients can’t get the care they need,” union leader Sal Rosselli said in a statement. Kaiser claims the union is… Read More
Hospital-Acquired Infections Dip, But Experts Say That There’s Still More Work To DoExperts say there are certain infection types--such as pneumonia or C. diff--that aren't showing any progress. Meanwhile, health care executives weigh in on what a politically divided Congress will mean to the hospital indust… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment